Viome Life Sciences announced it closed a $86.5 million oversubscribed Series C funding round, bringing its total raise to $175 million. Bold Capital and Khosla Ventures participated in the round ...

Viome's Full Body Intelligence Test ™ is the only science backed at-home test that decodes your body's biological signals to give you precision health insights. It reveals not just what's happening ...

Viome Life Sciences has snatched up Naring Health to build out its personalized nutrition offerings and further its goal to bring at-home diagnostics to the masses. The acquisition of digital health ...

BELLEVUE, Wash.--(BUSINESS WIRE)--Viome Life Sciences, a leading preventative health technology company committed to translating scientific advancements into practical and individualized health ...

First-of-its-kind 1,000-patient clinical study will use RNA-based stool and saliva tests to detect colon polyps — early warning signs of colorectal cancer — before they become cancerous. Study aims to ...

A collaboration between Viome Life Sciences and Scripps Research is set to develop and clinically validate the first ribonucleic acid (RNA) test aimed at detecting precancerous colon polyps. This ...

LOS ANGELES, CA, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- Dentulu, the nation’s leading Teledentistry platform and pioneer of innovative at-home ...

Study aims to enhance colorectal cancer prevention by identifying polyp molecular signals, offering improved sensitivity over at-home DNA tests, which have limited ability to detect precancerous ...